MYGN 13.36 (+1.44%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

43 / 56

Dividend yield

0 / 9

Total Cash

36 / 57

Performance 3 years

29 / 58

Performance 5 years

37 / 58

Performance 10 years

38 / 58

Linearity 3 years

22 / 58

Linearity 5 years

29 / 58

Linearity 10 years

17 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Market Capitalization - MYGN ranking 28 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by market capitalization
1. Thermo Fisher Scientific TMO
215.89B
2. Danaher DHR
188.52B
3. IDEXX Laboratories IDXX
47.78B
4. IQVIA Holdings IQV
45.29B
5. DexCom DXCM
44.46B
6. Agilent Technologies A
38.84B
7. Icon ICLR
26.6B
8. Mettler-Toledo MTD
26.06B
9. Illumina ILMN
22.21B
10. Waters WAT
19.67B
11. Laboratory Corp of America Holdings LH
18.14B
12. PerkinElmer PKI
14.46B
13. Quest Diagnostics DGX
14B
14. Charles River Laboratories CRL
12.99B
15. Medpace Holdings MEDP
12.41B
16. Exact Sciences EXAS
10.33B
17. Qiagen QGEN
9.63B
18. Natera NTRA
9.15B
19. Sotera Health SHC
4.9B
20. Lantheus Holdings LNTH
4.68B
21. Syneos Health SYNH
4.43B
22. Ortho Clinical Diagnostics Holdings OCDX
4.19B
23. Neogen NEOG
3.74B
24. Olink Holding OLK
2.8B
25. RadNet RDNT
2.6B
26. Guardant Health GH
2.38B
27. Twist Bioscience TWST
2.37B
28. Myriad Genetics MYGN
2.11B
29. NeoGenomics NEO
2.06B
30. Pacific Biosciences of California PACB
1.5B
31. Meridian Bioscience VIVO
1.49B
32. Heska HSKA
1.31B
33. National Research NRC
990.11M
34. Fulgent Genetics FLGT
755.05M
35. CareDx CDNA
513.39M
36. MaxCyte MXCT
481.63M
37. Global Cord Blood CO
400.08M
38. Bioventus BVS
310.42M
39. Sera Prognostics SERA
278.89M
40. Inotiv NOTV
170.48M
41. Biodesix BDSX
142.95M
42. MDxHealth MDXH
113.39M
43. Anixa Biosciences ANIX
112.58M
44. Neuronetics STIM
94.03M
45. Trinity Biotech TRIB
87.88M
46. Personalis PSNL
73.55M
47. Enzo Biochem ENZ
67.66M
48. DarioHealth DRIO
59.74M
49. Prenetics Global PRE
59.2M
50. Aspira Womens Health AWH
41.86M
51. Co-Diagnostics CODX
34.56M
52. Exagen XGN
33.58M
53. bioAffinity Technologies BIAF
19.57M
54. Psychemedics PMD
17.7M
55. Organovo Holdings ONVO
9.84M
56. Precipio PRPO
9.23M
57. Interpace Biosciences IDXG
4.54M
58. SeqLL SQL
2.57M
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.